We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Study Shows Zika Virus Persists in Body Fluids

By LabMedica International staff writers
Posted on 18 Oct 2018
Although most Zika virus (ZIKV) infections are transmitted by infected mosquitoes, ZIKV transmission has been documented as occurring through sexual contact, blood transfusion, laboratory exposure, and both intrauterine and intrapartum transmission.

ZIKV infection can be diagnosed through detection of ZIKV RNA in blood, urine, and other body fluids by reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assays. More...
However, the frequency with which ZIKV RNA can be detected in various body fluids and the length of time that it remains detectable are not well understood.

An international team of scientists cooperating with the Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA) evaluated samples obtained from 295 participants (including 94 men who provided semen specimens) in whom ZIKV RNA was detected on RT-PCR assay in urine or blood at an enhanced arboviral clinical surveillance site. The study was based on 295 people in Puerto Rico infected with Zika beginning in May 2016. The team collected samples of serum, urine, saliva, semen, and vaginal secretions weekly for the first month and at 2, 4, and 6 months after diagnosis. The mean age of the participants was 36 years; 51% were female, including nine who were pregnant.

Specimens, measuring 200 μL, were tested by means of the Trioplex RT-PCR assay, as recommended by the CDC for the detection of dengue, chikungunya, and ZIKV RNA. In addition, they performed validation analyses for the use of the Trioplex RT-PCR assay in semen. Serum was tested by means of anti–ZIKV IgM antibody capture enzyme-linked immunosorbent assay. ZIKV isolation was attempted through culture in a subset of semen and serum specimens.

The investigators reported that the median and 95th percentile for the time until the loss of Zika RNA detection were 15 days, and 41 days respectively, in serum; 11 days, and 34 days in urine; and 42 days and 120 days in semen. Less than 5% of participants had detectable Zika RNA in saliva or vaginal secretions. Compared with preliminary findings, the median time of RNA clearance in semen rose from 34 to 42 days, and for 95th percentile it climbed from 81 to 120 days.

The authors concluded that the prolonged time until ZIKV RNA clearance in serum in this study may have implications for the diagnosis and prevention of ZIKV infection. In 95% of the men in this study, ZIKV RNA was cleared from semen after approximately four months.

Gabriela Paz-Bailey, MD, PhD, the lead author of the study, said, “Anyone concerned about getting or passing Zika through sex should use condoms every time they have sex or not have sex for at least three months after symptom onset to allow Zika virus to clear from semen. Because Zika infection during pregnancy can cause severe birth defects, pregnant women should not travel to areas with Zika transmission risk. All travelers should strictly follow steps to prevent mosquito bites and prevent sexual transmission during and after the trip.” The study was published on September 27, 2018, in The New England Journal of Medicine.

Related Links:
Centers for Disease Control and Prevention


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Immunofluorescence Analyzer
IFA System
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study design and workflow (Parankusham H, Vanderlip C, Birkenbihl C, et al. A two-stage plasma biomarker algorithm reduces amyloid PET use and the p-Tau217 gray zone. Annals of Clinical and Translational Neurology. Published online October 19, 2026. doi:10.1002/acn3.70560)

Two-Step Blood Testing Approach Reduces Uncertainty in Amyloid Assessment

Blood-based biomarkers offer a more accessible, less expensive way to detect Alzheimer’s-related brain changes than traditional methods such as amyloid-beta positron emission tomography (Aβ-PET).... Read more

Molecular Diagnostics

view channel
Image: Tumor DNA is extracted from a pathology sample, and normal DNA is extracted from the buffy coat. Both samples undergo WGS to generate the patient-specific mutational signature. At each follow-up, ctDNA extracted from plasma undergoes WGS and is analyzed using a patient-derived signature and an artificial intelligence (AI) pattern recognition algorithm. FFPE: formalin fixed, paraffin embedded. (Snuderl M, Smadbeck J, Wilkins R, et al. The Journal of Molecular Diagnostics, 2026. DOI: 10.1016/j.jmoldx.2026.07.003)

Liquid Biopsy Detects Lung Cancer Recurrence Signals Months Before Imaging

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and remains a major cause of cancer-related death. Early-stage tumors are often treated surgically, but recurrence can still occur... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.